Pilocarpine

Active ingredient: Pilocarpine Hydrochloride

In short: Pilocarpine hydrochloride tablets are indicated for: The treatment of symptoms of dry mouth from salivary gland hypofunction caused by radiotherapy for cancer of the head and neck. The treatment of symptoms of dry mouth in patients with Sjogren’s Syndrome.

LabelAmneal Pharmaceuticals NY LLC
Label updatedApr 27, 2026

What is Pilocarpine used for?

Pilocarpine hydrochloride tablets are indicated for:

The treatment of symptoms of dry mouth from salivary gland hypofunction caused by radiotherapy for cancer of the head and neck.

The treatment of symptoms of dry mouth in patients with Sjogren’s Syndrome.

⚠ Boxed warning (FDA's strongest warning)

Patients with significant cardiovascular disease may be unable to compensate for transient changes in hemodynamics or rhythm induced by pilocarpine. Pulmonary edema has been reported as a complication of pilocarpine toxicity from high ocular doses given for acute angle-closure glaucoma. Pilocarpine should be administered with caution in and under close medical supervision of patients with significant cardiovascular disease.

Ocular formulations of pilocarpine have been reported to cause visual blurring which may result in decreased visual acuity, especially at night and in patients with central lens changes, and to cause impairment of depth perception. Caution should be advised while driving at night or performing hazardous activities in reduced lighting.

Pilocarpine has been reported to increase airway resistance, bronchial smooth muscle tone, and bronchial secretions. Pilocarpine hydrochloride should be administered with caution to and under close medical supervision in patients with controlled asthma, chronic bronchitis, or chronic obstructive pulmonary disease requiring pharmacotherapy.

Pilocarpine dosage

Regardless of the indication, the starting dose in patients with moderate hepatic impairment should be 5 mg twice daily, followed by adjustment based on therapeutic response and tolerability. Patients with mild hepatic insufficiency do not require dosage reductions. The use of pilocarpine in patients with severe hepatic insufficiency is not recommended. If needed, refer to the Hepatic Insufficiency subsection of the Precautions section of this label for definitions of mild, moderate and severe hepatic impairment.

The recommended initial dose of pilocarpine hydrochloride tablets is 5 mg taken three times a day. Dosage should be titrated according to therapeutic response and tolerability. The usual dosage range is up to 15 mg per day to 30 mg per day (Not to exceed 10 mg per dose). Although early improvement may be realized, at least 12 weeks of uninterrupted therapy with pilocarpine hydrochloride tablets may be necessary to assess whether a beneficial response will be achieved. The incidence of the most common adverse events increases with dose. The lowest dose that is tolerated and effective should be used for maintenance.

The recommended dose of pilocarpine hydrochloride tablets is one tablet (5 mg) taken four times a day. Efficacy was established by 6 weeks of use.

Warnings & precautions

Do not take this medicine if: Pilocarpine hydrochloride tablets are contraindicated in patients with uncontrolled asthma, known hypersensitivity to pilocarpine, and when miosis is undesirable, e.g., in acute iritis and in narrow-angle (angle closure) glaucoma.

Pilocarpine toxicity is characterized by an exaggeration of its parasympathomimetic effects. These may include: headache, visual disturbance, lacrimation, sweating, respiratory distress, gastrointestinal spasm, nausea, vomiting, diarrhea, atrioventricular block, tachycardia, bradycardia, hypotension, hypertension, shock, mental confusion, cardiac arrhythmia, and tremors.

The dose-related cardiovascular pharmacologic effects of pilocarpine include hypotension, hypertension, bradycardia, and tachycardia.

Pilocarpine should be administered with caution to patients with known or suspected cholelithiasis or biliary tract disease. Contractions of the gallbladder or biliary smooth muscle could precipitate complications including cholecystitis, cholangitis, and biliary obstruction.

Pilocarpine may increase ureteral smooth muscle tone and could theoretically precipitate renal colic (or “ureteral reflux”), particularly in patients with nephrolithiasis.

Cholinergic agonists may have dose-related central nervous system effects. This should be considered when treating patients with underlying cognitive or psychiatric disturbances.

Hepatic Insufficiency: Based on decreased plasma clearance observed in patients with moderate hepatic impairment, the starting dose in these patients should be 5 mg twice daily, followed by adjustment based on therapeutic response and tolerability. Patients with mild hepatic insufficiency (Child-Pugh score of 5 to 6) do not require dosage reductions. To date, pharmacokinetic studies in subjects with severe hepatic impairment (Child-Pugh score of 10 to 15) have not been carried out. …

Pilocarpine side effects

In controlled studies, 217 patients received pilocarpine, of whom 68% were men and 32% were women. Race distribution was 91% Caucasian, 8% Black, and 1% of other origin. Mean age was approximately 58 years. The majority of patients were between 50 and 64 years (51%), 33% were 65 years and older and 16% were younger than 50 years of age. The most frequent adverse experiences associated with pilocarpine hydrochloride tablets were a consequence of the expected pharmacologic effects of pilocarpine.

Adverse Event | Pilocarpine Hydrochloride | Placebo

10 mg three times a day

(30 mg/day) | 5 mg three times a day

(15 mg/day) | (three times a day)

Sweating | N = 121/68% | N = 141/29% | N= 152/9%

Nausea | 15 | 6 | 4

Rhinitis | 14 | 5 | 7

Diarrhea | 7 | 4 | 5

Chills | 15 | 3 | <1

Flushing | 13 | 8 | 3

Urinary Frequency | 12 | 9 | 7

Dizziness | 12 | 5 | 4

Asthenia | 12 | 6 | 3

In addition, the following adverse events (≥3% incidence) were reported at dosages of 15 mg/day to 30 mg/day in the controlled clinical trials:

Adverse Event | Pilocarpine Hydrochloride | Placebo

5 mg to 10 mg three times a day

(15 mg/day to 30 mg/day) | (three times a day)

Headache | N = 212/11% | N = 152/8%

Dyspepsia | 7 | 5

Lacrimation | 6 | 8

Edema | 5 | 4

Abdominal Pain | 4 | 4

Amblyopia | 4 | 2

Vomiting | 4 | 1

Pharyngitis | 3 | 8

Hypertension | 3 | 1

The following events were reported with treated head and neck cancer patients at incidences of 1% to 2% at dosages of 7.5 mg/day to 30 mg/day: abnormal vision, …

About this medicine

Pilocarpine hydrochloride tablets, USP contain pilocarpine hydrochloride,USP, a cholinergic agonist for oral use. Pilocarpine hydrochloride, USP is a white crystalline powder or colorless crystals, hygroscopic which is soluble in water and alcohol and virtually insoluble in most non-polar solvents. Pilocarpine hydrochloride, with a chemical name of (3S-cis)-2(3H)-Furanone, 3-ethyl-dihydro-4-[(1-methyl-1H-imidazol-5-yl) methyl] monohydrochloride, has a molecular weight of 244.72 g/mol.

Each 5 mg pilocarpine hydrochloride tablet, USP for oral administration contains 5 mg of pilocarpine hydrochloride, USP. Inactive ingredients in the tablet and the tablet’s film coating are: colloidal silicon dioxide, hypromellose Type 2910/ 3cP, 6cP, and 50cP, polyethylene glycol, microcrystalline cellulose, stearic acid, polydextrose, titanium dioxide, triacetate and triacetin.

How it works: Pilocarpine is a cholinergic parasympathomimetic agent exerting a broad spectrum of pharmacologic effects with predominant muscarinic action. …

Disclaimer: This page is for general information only and is not medical advice. It is a condensed summary of the official FDA-approved label — it does not replace the full prescribing information or the advice of your doctor or pharmacist. Always follow your prescriber's instructions and read the medication guide that comes with your medicine.

Source: FDA-approved label via DailyMed (U.S. National Library of Medicine), label set ID 6272ccac-b543-404d-9938-8583bb59ed2c. Read the full official label on DailyMed.

Related medicines

Levothyroxine Allopurinol Ondansetron Finasteride Clonidine Testosterone Thyroid Methotrexate